Fidaxomicin has shown promise as an effective treatment option for Clostridium difficile infections, but no pharmacoeconomic studies have been performed to date.
Jason W. Lancaster, PharmD, BCPS
Advertisement
Articles by Jason W. Lancaster, PharmD, BCPS
Advertisement
Latest Updated Articles
- Economic Impact of Fidaxomicin on CDI Treatment in United States
Published: June 12th 2012 | Updated:
Advertisement
Advertisement
